BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 26031747)

  • 1. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.
    Gach A; Pinkier I; Szarras-Czapnik M; Sakowicz A; Jakubowski L
    Reprod Biol Endocrinol; 2020 Jan; 18(1):8. PubMed ID: 31996231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
    Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
    Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism.
    Pitteloud N; Acierno JS; Meysing A; Eliseenkova AV; Ma J; Ibrahimi OA; Metzger DL; Hayes FJ; Dwyer AA; Hughes VA; Yialamas M; Hall JE; Grant E; Mohammadi M; Crowley WF
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6281-6. PubMed ID: 16606836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical genetics of Kallmann syndrome.
    Dodé C; Hardelin JP
    Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.
    Bianco SD; Kaiser UB
    Nat Rev Endocrinol; 2009 Oct; 5(10):569-76. PubMed ID: 19707180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two novel missense mutations in the KAL1 gene in Han Chinese subjects with Kallmann Syndrome.
    Jap TS; Chiu CY; Lirng JF; Won GS
    J Endocrinol Invest; 2011 Jan; 34(1):53-9. PubMed ID: 20530987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
    Gonçalves CI; Fonseca F; Borges T; Cunha F; Lemos MC
    Hum Reprod; 2017 Mar; 32(3):704-711. PubMed ID: 28122887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland.
    Laitinen EM; Vaaralahti K; Tommiska J; Eklund E; Tervaniemi M; Valanne L; Raivio T
    Orphanet J Rare Dis; 2011 Jun; 6():41. PubMed ID: 21682876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROKR2 mutations in autosomal recessive Kallmann syndrome.
    Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
    Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
    Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
    Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.